DataMeds AI, Inc. (MEDS)
0.9606
-0.21
(-17.90%)
USD |
NASDAQ |
Aug 28, 16:00
0.9702
+0.01
(+1.00%)
After-Hours: 20:00
DataMeds AI Total Liabilities (Quarterly) : 52.26M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.26M |
| March 31, 2026 | 45.19M |
| December 31, 2025 | 42.91M |
| September 30, 2025 | 46.00M |
| June 30, 2025 | 53.32M |
| March 31, 2025 | 53.58M |
| Date | Value |
|---|---|
| December 31, 2024 | 50.60M |
| September 30, 2024 | 45.59M |
| June 30, 2024 | 7.322M |
| March 31, 2024 | 3.871M |
| December 31, 2023 | 3.239M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | 0.1038M |
| Xcelerate, Inc. | 2.332M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | 0.4484M |
| Vivos Therapeutics, Inc. | 28.13M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.76M |
| Shareholders Equity (Quarterly) | -19.50M |
| Debt to Equity Ratio | -1.681 |
| Current Ratio | 0.1429 |
| Net Debt Paydown Yield | -16.03% |